MBX Biosciences, Inc. Common Stock
MBX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Market Cap | $615,426 | $753,340 | $753,340 |
| - Cash | $49,351 | $30,523 | $24,210 |
| + Debt | $171 | $324 | $461 |
| Enterprise Value | $566,246 | $723,141 | $729,591 |
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Gross Profit | $0 | $0 | $0 |
| % Margin | – | – | – |
| EBITDA | -$67,950 | -$35,154 | -$25,705 |
| % Margin | – | – | – |
| Net Income | -$61,922 | -$32,563 | -$26,135 |
| % Margin | – | – | – |
| EPS Diluted | -1.85 | -1.02 | -0.82 |
| % Growth | -81.4% | -24.4% | – |
| Operating Cash Flow | -$54,681 | -$31,978 | -$23,122 |
| Capital Expenditures | -$874 | -$129 | -$441 |
| Free Cash Flow | -$55,555 | -$32,107 | -$23,563 |